ORIONS Money Stocks

[AugustaFriends]

Pharmas on watch - FDA Approval this week.

Sept. 12-15 Interscience Conference on Antimicrobial Agents and Chemotherapy annual meeting. Expect data from Optimer Pharmaceuticals(OPTR) (fidaxomicin), Cubist Pharmaceuticals(CBST) (CXA-101) and GlaxoSmithKline(GSK) (GSK2248761).
Rodman & Renshaw Annual Global Investment Conference
Sept. 13-14
Morgan Stanley Global Healthcare Conference
Sept. 14 FDA approval decision: Savient Pharmaceuticals'(SVNT) Krystexxa for gout.
Sept. 14-15
Baird 2010 Health Care Conference
Sept. 15 FDA advisory panel meeting: Abbott Labs'(ABT) obesity drug Meridia (safety review).
Sept. 16 FDA advisory panel meetings: Arena Pharmaceuticals'(ARNA) lorcaserin in obesity and Alkermes'(ALKS) Vivitrol Opioid for opioid addiction.